Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide

M W Owens1, M B Grisham

  • 1Department of Medicine, Overton Brooks Veterans Affairs Medical Center, Shreveport, Louisiana 71101-4295.

Insights

Pleural mesothelial cells (PMC) produce nitric oxide (NO) when exposed to combinations of inflammatory cytokines and bacterial products. This NO production, measured via nitrite/nitrate, is significant and L-arginine dependent.

Area of Science:

  • Immunology
  • Cell Biology
  • Respiratory Medicine

Background:

  • Pleural inflammation involves close contact between mesothelial cells and leukocytes.
  • Leukocyte-derived products, such as cytokines, may influence mesothelial cell function.

Purpose of the Study:

  • To investigate if cytokines and bacterial products induce nitric oxide (NO) production in pleural mesothelial cells (PMC).

Main Methods:

  • Rat PMC monolayers were treated with tumor necrosis factor (TNF), interleukin-1 beta (IL-1), gamma-interferon (IFN), and lipopolysaccharide (LPS) individually and in combinations.
  • Nitrite and nitrate concentrations were measured as indirect indicators of NO production over 6-72 hours.
  • Inhibition studies using NG-nitro-L-arginine methyl ester confirmed L-arginine-dependent NO synthesis.

Main Results:

  • PMC produced nitric oxide (NO) in response to specific cytokine and LPS combinations.
  • Maximal NO production occurred at 72 hours, particularly with triple combinations (LPS, IL-1, TNF).
  • NG-nitro-L-arginine methyl ester significantly inhibited NO production, confirming its L-arginine-dependent pathway.

Conclusions:

  • Pleural mesothelial cells possess the capacity to generate substantial amounts of nitric oxide (NO).
  • Pro-inflammatory cytokines and bacterial products, especially in combination, are potent inducers of NO production by PMC.
  • This finding highlights a potential mechanism in pleural inflammation involving mesothelial cell-derived NO.